EUVIMEDEUVIMED entdecken
Crossref

Colonic (poly)phenol metabolites as promising tools to control inflammation and prevent cardiovascular disease

Paola Bonicco, Beatrice Mattina, Claudio Curti, Carmine Giorgio, Massimiliano Tognolini, Claudia Favari, Pedro Mena, Nicoletta Ronda, Ilaria Zanotti

European Atherosclerosis Journal · 30.04.2026 · 5 (1) · 22

DOI: 10.56095/eaj.v5i1.129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Atherosclerosis Journal, online erschienen am 30.04.2026. Verfasst von Paola Bonicco und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Chronic inflammation underlies numerous diseases, including atherosclerosis. The identification of anti-inflammatory agents, particularly from dietary sources, is of great interest for the development of functional products targeting early stages of chronic inflammatory conditions. This study investigated the in vitro anti-inflammatory activity of chiral phenyl-γ-valerolactones, the main colonic metabolites of flavan-3-ols.

Methods

Human dermal fibroblasts were treated with 10 phenyl-γ-valerolactones (1 μM) for 48 hours. Compounds included pure enantiomers and methylated or sulfated derivatives, tested at concentrations representative of plasma levels following dietary intake. During the first 24 hours, cells were treated under basal conditions; during the second 24 hours, treatments were repeated in the presence or absence of lipopolysaccharide (LPS, 1 μg/mL). Cytotoxicity was assessed by MTT and lactate dehydrogenase assays (LDH). Anti-inflammatory activity was evaluated by measuring IL-6 and IL-8 secretion using ELISA, with data normalized to protein content (bicinchoninic acid assay). To investigate the underlying mechanism of action, NF-κB activation was assessed by western blot analysis of p65 expression, normalized to β-actin. A 24-hour pharmacokinetic study was conducted to evaluate compound biotransformation and to characterize metabolic products, monitoring 31 phenyl-γ-valerolactones.

Results

None of the tested compounds induced cytotoxicity. (4R)-5-(4ʹ-hydroxyphenyl)-γ-valerolactone (R-CC01) reduced IL-6 and IL-8 secretion by 76% (p

Zitieren

APA

Bonicco, P., Mattina, B., Curti, C., Giorgio, C., Tognolini, M., Favari, C., Mena, P., Ronda, N., & Zanotti, I. (2026). Colonic (poly)phenol metabolites as promising tools to control inflammation and prevent cardiovascular disease. European Atherosclerosis Journal, 5(1), 22. https://doi.org/10.56095/eaj.v5i1.129

Vancouver

Bonicco P, Mattina B, Curti C, Giorgio C, Tognolini M, Favari C, et al. Colonic (poly)phenol metabolites as promising tools to control inflammation and prevent cardiovascular disease. European Atherosclerosis Journal. 2026;5(1):22. doi:10.56095/eaj.v5i1.129

BibTeX
@article{Bonicco2026,
  author = {Bonicco, Paola and Mattina, Beatrice and Curti, Claudio and Giorgio, Carmine and Tognolini, Massimiliano and Favari, Claudia and Mena, Pedro and Ronda, Nicoletta and Zanotti, Ilaria},
  title = {Colonic (poly)phenol metabolites as promising tools to control inflammation and prevent cardiovascular disease},
  journal = {European Atherosclerosis Journal},
  year = {2026},
  volume = {5},
  number = {1},
  pages = {22},
  doi = {10.56095/eaj.v5i1.129}
}
Kostenlos starten →